ArticleBlood advances2026
A comprehensive multicenter study assessing the impact of abelacimab, asundexian, and milvexian on coagulation assays.
Laurie Goubeau et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it